230 related articles for article (PubMed ID: 18097774)
1. IgM antibodies against dsDNA in SLE.
Witte T
Clin Rev Allergy Immunol; 2008 Jun; 34(3):345-7. PubMed ID: 18097774
[TBL] [Abstract][Full Text] [Related]
2. Anti-dsDNA antibody isotypes in systemic lupus erythematosus: IgA in addition to IgG anti-dsDNA help to identify glomerulonephritis and active disease.
Villalta D; Bizzaro N; Bassi N; Zen M; Gatto M; Ghirardello A; Iaccarino L; Punzi L; Doria A
PLoS One; 2013; 8(8):e71458. PubMed ID: 23951169
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
[TBL] [Abstract][Full Text] [Related]
4. Anti-dsDNA antibodies in Brazilian patients of mainly African descent with systemic lupus erythematosus: lack of association with lupus nephritis.
Atta AM; Pereira MM; Santiago M; Sousa-Atta ML
Clin Rheumatol; 2009 Jun; 28(6):693-7. PubMed ID: 19283331
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of anti-dsDNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis.
Förger F; Matthias T; Oppermann M; Becker H; Helmke K
Lupus; 2004; 13(1):36-44. PubMed ID: 14870916
[TBL] [Abstract][Full Text] [Related]
6. IgM anti-dsDNA antibodies in systemic lupus erythematosus: negative association with nephritis. SLE Study Group.
Witte T; Hartung K; Sachse C; Matthias T; Fricke M; Deicher H; Kalden JR; Lakomek HJ; Peter HH; Schmidt RE
Rheumatol Int; 1998; 18(3):85-91. PubMed ID: 9833247
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies in Systemic Lupus Erythematosus Target Mitochondrial RNA.
Becker Y; Marcoux G; Allaeys I; Julien AS; Loignon RC; Benk-Fortin H; Rollet-Labelle E; Rauch J; Fortin PR; Boilard E
Front Immunol; 2019; 10():1026. PubMed ID: 31134086
[TBL] [Abstract][Full Text] [Related]
8. Is alpha-actinin a target for pathogenic anti-DNA antibodies in lupus nephritis?
Mason LJ; Ravirajan CT; Rahman A; Putterman C; Isenberg DA
Arthritis Rheum; 2004 Mar; 50(3):866-70. PubMed ID: 15022329
[TBL] [Abstract][Full Text] [Related]
9. An antibody profile of systemic lupus erythematosus detected by antigen microarray.
Fattal I; Shental N; Mevorach D; Anaya JM; Livneh A; Langevitz P; Zandman-Goddard G; Pauzner R; Lerner M; Blank M; Hincapie ME; Gafter U; Naparstek Y; Shoenfeld Y; Domany E; Cohen IR
Immunology; 2010 Jul; 130(3):337-43. PubMed ID: 20201986
[TBL] [Abstract][Full Text] [Related]
10. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.
Zhao Z; Weinstein E; Tuzova M; Davidson A; Mundel P; Marambio P; Putterman C
Arthritis Rheum; 2005 Feb; 52(2):522-30. PubMed ID: 15693007
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
Wang H; Li T; Chen S; Gu Y; Ye S
Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
[TBL] [Abstract][Full Text] [Related]
12. IgG, IgM, and IgA antinuclear antibodies in discoid and systemic lupus erythematosus patients.
Jost SA; Tseng LC; Matthews LA; Vasquez R; Zhang S; Yancey KB; Chong BF
ScientificWorldJournal; 2014; 2014():171028. PubMed ID: 24741342
[TBL] [Abstract][Full Text] [Related]
13. Circulating DNA-anti-DNA complexes in lupus nephritis and idiopathic nephritis.
Williams DG; Adu D
Proc Eur Dial Transplant Assoc; 1980; 17():629-36. PubMed ID: 6787585
[TBL] [Abstract][Full Text] [Related]
14. The predictive value of fluctuations in IgM and IgG class anti-dsDNA antibodies for relapses in systemic lupus erythematosus. A prospective long-term observation.
Bootsma H; Spronk PE; Ter Borg EJ; Hummel EJ; de Boer G; Limburg PC; Kallenberg CG
Ann Rheum Dis; 1997 Nov; 56(11):661-6. PubMed ID: 9462168
[TBL] [Abstract][Full Text] [Related]
15. Treatment with dsDNA-anti-dsDNA antibody complexes extends survival, decreases anti-dsDNA antibody production and reduces severity of nephritis in MRLlpr mice.
Burny W; Lebrun P; Cosyns JP; Saint-Remy JM
Lupus; 1997; 6(1):4-17. PubMed ID: 9116717
[TBL] [Abstract][Full Text] [Related]
16. Anti-DNA idiotypes and anti-idiotypes in systemic lupus erythematosus.
Sasaki T
Jpn J Med; 1990; 29(6):655-6. PubMed ID: 2101419
[No Abstract] [Full Text] [Related]
17. C-reactive protein, immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus nephritis.
Sjöwall C; Olin AI; Skogh T; Wetterö J; Mörgelin M; Nived O; Sturfelt G; Bengtsson AA
Autoimmunity; 2013 May; 46(3):205-14. PubMed ID: 23331132
[TBL] [Abstract][Full Text] [Related]
18. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
[TBL] [Abstract][Full Text] [Related]
19. Activation-induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis.
Jiang C; Zhao ML; Scearce RM; Diaz M
Arthritis Rheum; 2011 Apr; 63(4):1086-96. PubMed ID: 21225690
[TBL] [Abstract][Full Text] [Related]
20. Immune recognition of DNA in SLE.
Pisetsky DS
Clin Immunol Immunopathol; 1998 Jan; 86(1):1-2. PubMed ID: 9434790
[No Abstract] [Full Text] [Related]
[Next] [New Search]
